Physician profile
Charles W Mitchell
NPI 1285730705
$429.25
in general payments reported to CMS, 2019-2025
11 companies · $40.86 in 2025
The $40.86 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $54.67 · 2022: $23.36 · 2023: $13.61 · 2024: $135 · 2025: $40.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $116 · Food and Beverage: $73.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $116.00 |
| Food and Beverage | $73.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $188.63 | 2019-2025 | Ozempic, Wegovy |
| Medtronic, INC. | $42.09 | 2022-2024 | Vanta Adaptivestim |
| Abbott Laboratories | $39.19 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Proclaim |
| Merck Sharp & Dohme LLC | $33.77 | 2019 | |
| Pfizer INC. | $28.92 | 2020 | |
| Vertical Pharmaceuticals, LLC | $21.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.95 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.95 | 2019 | |
| Mannkind Corporation | $13.85 | 2020 | |
| Glaxosmithkline, LLC. | $13.24 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.